FNY Managed Accounts’s AstraZeneca AZN Stock Holding History

FNY Managed Accounts’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-174	Closed	-$10K	–	204
2017 Q1	$10K	Buy	+174	New	+$10.1K	0.03%	485
2016 Q2	–	Sell	-1,650	Closed	-$92.9K	–	304
2016 Q1	$92.9K	Buy	+1,650	New	+$99.1K	0.16%	100

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

FNY Managed Accounts's AZN Position: Q2 2017 in Review

FNY Managed Accounts sold out of AstraZeneca (AZN) in Q2 2017, closing a stake of 174 shares — an estimated $10K sold.

FNY Managed Accounts first reported a position in AZN in Q1 2016 and held it in 2 quarters. The position peaked at $92.9K in Q1 2016. 466 funds tracked by Wall St. Rank hold AZN as of Q2 2017.

FNY Managed Accounts reported no remaining AstraZeneca position as of Q2 2017 after selling out during the quarter.
FNY Managed Accounts sold 174 AstraZeneca shares in Q2 2017, an estimated $10K.
FNY Managed Accounts first reported a position in AstraZeneca in Q1 2016 and held it in 2 quarters.
FNY Managed Accounts's AstraZeneca position peaked at $92.9K in Q1 2016.
466 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.